MURRAY JAMES B JR 13D and 13G filings for Acumen Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-01-24 4:22 pm Purchase |
2023-12-31 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
MURRAY JAMES B JR | 2,681,057 4.600% |
100,000 (+3.87%) |
Filing |
| 2022-02-14 4:03 pm Purchase |
2021-07-06 | 13G | Acumen Pharmaceuticals, Inc. ABOS |
MURRAY JAMES B JR | 2,581,057 6.400% |
2,581,057 (New Position) |
Filing |